|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,584 GBX | -0.41% |
|
-2.79% | +9.19% |
| Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
| Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
(Reuters) - British drugmaker GSK Plc said on Tuesday it had initiated the process for withdrawal of the U.S. approval for its blood cancer drug Blenrep, after the therapy failed to meet the requirements of a key trial.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Rashmi Aich)
| 1st Jan change | Capi. | |
|---|---|---|
| +9.19% | 80.88B | |
| +27.67% | 676B | |
| +23.58% | 554B | |
| -7.47% | 349B | |
| +14.50% | 318B | |
| +6.38% | 291B | |
| +2.96% | 210B | |
| -0.41% | 204B | |
| -10.02% | 194B | |
| -12.04% | 144B |
GSK PLC 
